Study in Women With Advanced Breast Cancer Receiving Palbociclib With AI or Fulvestrant

Clinical trial NCT02894398 · COMPLETED

Trial details

NCT number: NCT02894398
Sponsor: iOMEDICO AG
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Hormone Receptor Positive Tumor Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

Start date: 2016-09-06
Primary completion: 2023-02-15
Enrollment: 388

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.